Otsuka Holdings
4578.T
#749
Rank
โ‚น2.787 T
Marketcap
โ‚น5,279
Share price
0.44%
Change (1 day)
8.30%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2025 (TTM): โ‚น258.54

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is โ‚น276.36. In 2024 the company made an earnings per share (EPS) of โ‚น362.66 an increase over its 2023 EPS that were of โ‚น142.83.

EPS history for Otsuka Holdings from 2009 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น258.54-28.71%
2024โ‚น362.66153.9%
2023โ‚น142.83-15.71%
2022โ‚น169.45-6.18%
2021โ‚น180.61-24.1%
2020โ‚น237.9722.95%
2019โ‚น193.5456.13%
2018โ‚น123.96-25.11%
2017โ‚น165.5425.99%
2016โ‚น131.39-6.37%
2015โ‚น140.34
2014N/A-100%
2013โ‚น211.4418.06%
2012โ‚น179.091.01%
2011โ‚น177.2929.07%
2010โ‚น137.37-94.47%
2009โ‚น2,483